Cavalier Investments’s Enzymotec Ltd ENZY Stock Holding History

Cavalier Investments’s Portfolio ENZY Stock Details ENZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-22,000	Closed	-$261K	–	206
2017 Q4	$261K	Buy	+22,000	New	+$255K	0.1%	125

Cavalier Investments's ENZY Position: Q1 2018 in Review

Cavalier Investments sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 22,000 shares — an estimated $261K sold.

Cavalier Investments first reported a position in ENZY in Q4 2017 and held it in 1 quarter. The position peaked at $261K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.

Cavalier Investments reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
Cavalier Investments sold 22,000 Enzymotec Ltd shares in Q1 2018, an estimated $261K.
Cavalier Investments first reported a position in Enzymotec Ltd in Q4 2017 and held it in 1 quarter.
Cavalier Investments's Enzymotec Ltd position peaked at $261K in Q4 2017.
0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.

Based on Cavalier Investments's 13F filing for Q1 2018, filed 10 May 2018.